Naproxen
- Product NDC
- 50844-271
- 11-digit product format
- 508440271
- Labeler code
- 50844
- Product ID
- 50844-271_785c9c93-2a92-4405-ae16-e3720ad506ad
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Naproxen Sodium
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- L.N.K. International, Inc.
- Application
- ANDA079096
- Marketing category
- ANDA
- Marketing start
- 2019-09-12
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN SODIUM
- Active strength
- 220 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50844-271-43 | 50844027143 | 60 POUCH in 1 CARTON (50844-271-43) > 1 TABLET in 1 POUCH | 60 pouch | 2019-09-12 | 0000-00-00 | No | No | Current |